Elevance Health (ELV) Revenue — Quarter Ended Jun 30, 2023
Revenue increased in the reported quarter, continuing the upward trend seen in recent periods. The company's top-line growth was evident both sequentially and on an annual basis.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue increased in the reported quarter, continuing the upward trend seen in recent periods. The company's top-line growth was evident both sequentially and on an annual basis.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$43.7B
Revenue reported for this quarter.
Quarter-over-quarter
+3.6%
Change from the immediately preceding quarter.
Year-over-year
+13.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$165.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $39.9B | +11.5% |
| Dec 31, 2022 | $39.9B | +9.2% |
| Mar 31, 2023 | $42.2B | +10.7% |
| Jun 30, 2023 | $43.7B | +13.0% |
Revenue performance
Revenue for the quarter was higher than the preceding quarter, reflecting continued business expansion. The reported revenue also exceeded the level achieved in the same quarter a year earlier.
Quarterly comparison
Compared to the immediately preceding quarter, revenue showed a sequential increase. Relative to the same quarter one year earlier, revenue registered a significant rise.
What to watch
Monitor the sustainability of revenue growth momentum in upcoming quarters.